Company registration number 07183054 (England and Wales)
COUNTINGLAB LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
COUNTINGLAB LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
COUNTINGLAB LTD
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
5
737
1,803
Current assets
Debtors
6
37,972
550
Cash at bank and in hand
995
133,409
38,967
133,959
Creditors: amounts falling due within one year
7
(25,505)
(39,296)
Net current assets
13,462
94,663
Total assets less current liabilities
14,199
96,466
Creditors: amounts falling due after more than one year
8
(228,703)
(211,347)
Net liabilities
(214,504)
(114,881)
Capital and reserves
Called up share capital
126
126
Share premium account
26,000
26,000
Profit and loss reserves
(240,630)
(141,007)
Total equity
(214,504)
(114,881)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

COUNTINGLAB LTD
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 9 December 2025 and are signed on its behalf by:
Dr C P Singleton
Director
Company Registration No. 07183054
COUNTINGLAB LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Countinglab Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 30 Upper High Street, Thame, Oxfordshire, OX9 3EZ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Intangible fixed assets
20% straight line basis
COUNTINGLAB LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment
33% straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

COUNTINGLAB LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

COUNTINGLAB LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
3
4
Intangible fixed assets
Intangible fixed assets
£
Cost
At 1 April 2024 and 31 March 2025
93,500
Amortisation and impairment
At 1 April 2024 and 31 March 2025
93,500
Carrying amount
At 31 March 2025
-
0
At 31 March 2024
-
0
5
Tangible fixed assets
Computer equipment
£
Cost
At 1 April 2024 and 31 March 2025
8,534
Depreciation and impairment
At 1 April 2024
6,731
Depreciation charged in the year
1,066
At 31 March 2025
7,797
COUNTINGLAB LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
5
Tangible fixed assets
Computer equipment
£
(Continued)
- 7 -
Carrying amount
At 31 March 2025
737
At 31 March 2024
1,803
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
26,401
1
Corporation tax recoverable
9,093
-
0
Prepayments and accrued income
345
549
35,839
550
2025
2024
Amounts falling due after more than one year:
£
£
Corporation tax recoverable
2,133
-
0
Total debtors
37,972
550
7
Creditors: amounts falling due within one year
2025
2024
£
£
Other borrowings
2,853
7,038
Trade creditors
1,363
20
Taxation and social security
9,271
28,436
Other creditors
7,918
1,715
Accruals and deferred income
4,100
2,087
25,505
39,296
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
228,703
211,347
COUNTINGLAB LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
8
Creditors: amounts falling due after more than one year
(Continued)
- 8 -

Included in ‘Other creditors’ is a convertible loan of £67,500. The loan agreement has a repayment option and under the terms of the loan the noteholder is entitled to convert the loan into Ordinary shares if a Valuation Event occurs. 

The noteholder has acknowledged that no relevant Valuation Event has yet occurred and that none are currently forecast or planned.

The convertible loan note provides for interest of the higher of base rate plus 4% or 8% per annum, which is reflected in the loan balance. The total value of the loan in the accounts is £195,057 at 31 March 2025 (£178,551 at 31 March 2024), including the principal and unpaid interest.

 

The directors don't believe the equity component of the loan will be converted into shares and no adjustment has been made in the accounts. The directors believe there is no material difference between the value of the loan shown in the accounts and recalculating the liability component with an effective interest rate based on the market rate of interest.

9
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
444
444
2025-03-312024-04-01falsefalsefalse09 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityMr O GarlandProfessor P GrindrodDr C P Singleton071830542024-04-012025-03-31071830542025-03-31071830542024-03-3107183054core:ComputerEquipment2025-03-3107183054core:ComputerEquipment2024-03-3107183054core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3107183054core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3107183054core:Non-currentFinancialInstrumentscore:AfterOneYear2025-03-3107183054core:Non-currentFinancialInstrumentscore:AfterOneYear2024-03-3107183054core:CurrentFinancialInstruments2025-03-3107183054core:CurrentFinancialInstruments2024-03-3107183054core:ShareCapital2025-03-3107183054core:ShareCapital2024-03-3107183054core:SharePremium2025-03-3107183054core:SharePremium2024-03-3107183054core:RetainedEarningsAccumulatedLosses2025-03-3107183054core:RetainedEarningsAccumulatedLosses2024-03-3107183054bus:Director32024-04-012025-03-3107183054core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107183054core:PatentsTrademarksLicencesConcessionsSimilar2024-04-012025-03-3107183054core:ComputerEquipment2024-04-012025-03-31071830542023-04-012024-03-3107183054core:PatentsTrademarksLicencesConcessionsSimilar2024-03-3107183054core:PatentsTrademarksLicencesConcessionsSimilar2025-03-3107183054core:PatentsTrademarksLicencesConcessionsSimilar2024-03-3107183054core:ComputerEquipment2024-03-3107183054core:Non-currentFinancialInstruments2025-03-3107183054core:Non-currentFinancialInstruments2024-03-3107183054core:Non-currentFinancialInstruments12025-03-3107183054core:Non-currentFinancialInstruments12024-03-3107183054bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107183054bus:FRS1022024-04-012025-03-3107183054bus:AuditExemptWithAccountantsReport2024-04-012025-03-3107183054bus:Director12024-04-012025-03-3107183054bus:Director22024-04-012025-03-3107183054bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107183054bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP